KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Other Non-Current Liabilities (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Other Non-Current Liabilities for 14 consecutive years, with $171000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $171000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $171000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $171000.0 for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $171000.0 at Biolife Solutions, down from $2.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $5.5 million in Q2 2021, with the low at $42000.0 in Q4 2021.
  • Average Other Non-Current Liabilities over 3 years is $1.6 million, with a median of $171000.0 recorded in 2025.
  • The sharpest move saw Other Non-Current Liabilities tumbled 99.07% in 2021, then soared 5419.05% in 2022.
  • Over 3 years, Other Non-Current Liabilities stood at $42000.0 in 2021, then skyrocketed by 5419.05% to $2.3 million in 2022, then plummeted by 92.62% to $171000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $171000.0, $2.3 million, and $55000.0 for Q4 2025, Q4 2022, and Q3 2022 respectively.